Lawrence S Melvin, Jr

This inventor holds 57 USPTO granted patents, primarily in Pharmacological Compounds (CPC class 5462). Top assignee: Pfizer Corporation. Active years: 1978-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lawrence S Melvin, Jr. Retrieved from https://idiyas.com/inventor/lawrence-s-melvin-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 57

% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 11

Forward Citations = 321(Granted Patents)

Forward Citations (Not Self Cited) = 279(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Gales Ferry, CT (US) (1978 - 1983)
Groton, CT (US) (1990)
Ledyard, CT (US) (1981 - 2000)

Company Filing History:

57 out of 4,488

Pfizer Corporation

patents

Years Active: 1978-2000

Loading Chart...

Areas of Expertise:

Pharmacologically Active

Analgesics

Anti-inflammatory Agents

Asthma Treatments

Tetralin Derivatives

Chromans

Benzopyrans

Oxindole

Sulfonamides

CNS Agents

Dodecahydrotriphenylenes

Heteroarylmethoxyphenyl

57 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6166031 - Substituted tetralins, chromans and related compounds in the treatment (2000-12-26),

2. 5998451 - Substituted tetralins, chromans and related compounds in the treatment (1999-12-07),

3. 5952326 - Tetralin and chroman derivatives useful in the treatment of asthma, (1999-09-14),

4. 5698550 - Tetralin and chroman derivatives useful in the treatment of asthma, (1997-12-16),

5. 5550152 - Benzopyran and related LTB.sub.4 antagonists (1996-08-27),

6. 5384318 - Substituted sulfonamides and related compounds in the treatment of (1995-01-24),

7. 5298512 - Substituted chromans and their use in the treatment of asthma, arthritis (1994-03-29),

8. 5248685 - Substituted 1-[3-(heteroarylmethoxy)phenyl]alkanols and related (1993-09-28),

9. 5059609 - Substituted tetralins, chromans and related compounds in the treatment (1991-10-22),

10. 4940712 - Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors (1990-07-10),

11. 4933475 - Pharmacologically active (1990-06-12),

12. 4921994 - Pharmacologically active 2-hydroxy-4-(substituted) phenyl cycloalkanes (1990-05-01),

13. 4920221 - Substituted decahydro-1H-pyrido[1,2-f]phenanthridines and (1990-04-24),

14. 4870084 - Bicyclic benzo fused pyran compounds used for nausea treatment and (1989-09-26),

15. 4863934 - Bicyclic benzo fused pyran compounds used for producing analgesia (1989-09-05),

Title: Lawrence S. Melvin, Jr: Pioneering Inventor from Ledyard

Introduction: Lawrence S. Melvin, Jr is a distinguished inventor hailing from Ledyard, Connecticut. With a passion for innovation and a keen eye for problem-solving, he has made significant contributions to various fields through his inventive spirit.

Latest Patents: Lawrence S. Melvin, Jr holds several patents in the areas of renewable energy technologies, sustainable agriculture practices, and advanced medical devices. His recent patents showcase his commitment to creating solutions that address pressing global challenges.

Career Highlights: Throughout his career, Lawrence S. Melvin, Jr has worked tirelessly to bring his innovative ideas to life. His journey is marked by a series of groundbreaking inventions that have revolutionized industries and improved the quality of life for many.

Collaborations: Lawrence S. Melvin, Jr has collaborated with leading research institutions, universities, and companies to further develop and commercialize his inventions. His collaborative efforts have led to the successful implementation of his ideas on a global scale.

Conclusion: Lawrence S. Melvin, Jr's dedication to innovation and his remarkable contributions to the world of inventions make him a true pioneer in his field. His inventive spirit continues to inspire future generations of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]